Adaptive Phage Therapeutics Enters Collaboration and License Agreement with Hebrew University of Jerusalem and Hadassah Medical Center
Retrieved on:
Wednesday, May 24, 2023
Health, Other Health, Clinical Trials, Research, Science, Pharmaceutical, Biotechnology, Partnership, Al-Quds, Hebrew University of Jerusalem, Technology transfer, Quinone, Nidaa Khoury, Bacteriophage, Infection, Phage therapy, Multimedia, Staphylococcus, Doctor of Philosophy, Staphylococcus aureus, Acinetobacter baumannii, Pseudomonas aeruginosa, Hospital, Rimon School of Jazz and Contemporary Music, IPTC, Biomedicine, Patient, PubMed, Hadassah Medical Center, APT, Bacteria, European Society of Clinical Microbiology and Infectious Diseases, Medicine, Pharmaceutical industry, MD
Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, is pleased to announce a collaboration and license agreement with the Israeli Phage Therapy Center (IPTC) of the Hebrew University of Jerusalem and Hadassah Medical Center.
Key Points:
- Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, is pleased to announce a collaboration and license agreement with the Israeli Phage Therapy Center (IPTC) of the Hebrew University of Jerusalem and Hadassah Medical Center.
- APT also has the first right to evaluate additional phages discovered by IPTC researchers for inclusion in APT’s phage bank.
- “We are thrilled to enter into this collaboration and license agreement and to continue our work with Dr. Nir-Paz, Dr. Hazan, and the impressive group of phage scientists at Hebrew University and Hadassah Medical Center.
- I am thrilled to see the Israeli Phage Therapy Center entering into a collaboration and licensing agreement with Adaptive Phage Therapeutics, the leading phage therapy biotech firm,” said Ran Nir-Paz, MD, Professor of Clinical Microbiology and Medicine at the department of Clinical Microbiology and Infectious Diseases at the Hadassah Hebrew University Medical Center and co-founder of the Israeli Phage Therapy Center.